Page 44 - 2016-2021-ISU

medical carrier to solicit and contract with credentialed radiological

providers to provide mammography screening, according to the American

Cancer Society's medical protocols, at the worksite and/or predetermined
location. Reimbursement will be provided in accordance with the

participating provider program, subject to the diagnostic copayment.
(6) The continuation of the ambulatory surgery benefit and monitoring of

participating centers. The Joint Committee on Health Benefits will work
with the State to oversee the solicitation by the medical/surgical/basic

medical carrier of Ambulatory Surgical Centers in bordering states and in
those states where retirees commonly reside.

(7) The continuation of the Home Care Advocacy Program (HCAP) and
the ongoing review of services offered. The JCHB shall work with the State

to review and monitor the utilization of DME under HCAP, specifically
requests, approvals and denials of duplicate equipment. If necessary the

State and CSEA Joint Committee will take appropriate action to address
the issue.

(8) The Joint Committee on Health Benefits will continue to review the
impact of Domestic Partner coverage.

(9) The Joint Committee on Health Benefits will work with the State to
monitor and oversee the Specialty Pharmacy Program.

(10) If reimportation of prescription drugs becomes permissible under
applicable law, rule, regulation or other appropriate approval, the parties

agree to work through the JCHB to explore the plan’s use of such
reimported drugs and evaluate the overall impact to the Empire Plan

Prescription Drug Program. The parties will determine whether to

recommend the implementation of the plan’s utilization of such drugs if
both parties agree that it is practicable, cost effective and able to be
implemented into and become part of the current Empire Plan prescription

drug program. Implementation of the alternative drug program for CSEA-

represented employees will not take place without the agreement of the
CSEA JCHB.

(11) The JCHB will work with the State and the Empire Plan prescription
drug carriers to monitor and oversee the Enhanced Flexible Formulary. No

changes to the Enhanced Flexible Formulary shall occur without notifying
the Joint Committee in advance of the change(s).

(12) The JCHB will work with the State to develop a voluntary Value

43